Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

BACKGROUND: For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine (pharmaceutical grade heroin). While this treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Palis, Heather, MacDonald, Scott, Jun, Jennifer, Oviedo-Joekes, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136105/
https://www.ncbi.nlm.nih.gov/pubmed/34016137
http://dx.doi.org/10.1186/s12954-021-00500-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136105/
https://www.ncbi.nlm.nih.gov/pubmed/34016137
http://dx.doi.org/10.1186/s12954-021-00500-9

Ejemplares similares